Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
grade B 22.68 -3.53% -0.83
MGNX closed down 3.53 percent on Thursday, June 21, 2018, on 67 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical MGNX trend table...

Date Alert Name Type % Chg
Jun 21 Bearish Engulfing Bearish 0.00%
Jun 21 Outside Day Range Expansion 0.00%
Jun 21 Overbought Stochastic Strength 0.00%
Jun 21 Upper Bollinger Band Touch Strength 0.00%
Jun 20 NR7 Range Contraction -3.53%
Jun 20 Stochastic Reached Overbought Strength -3.53%
Jun 20 Gapped Up Strength -3.53%
Jun 20 Overbought Stochastic Strength -3.53%
Jun 19 Crossed Above 50 DMA Bullish -1.18%
Jun 19 MACD Bullish Centerline Cross Bullish -1.18%

Older signals for MGNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.
Is MGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.74
52 Week Low 14.36
Average Volume 284,851
200-Day Moving Average 21.4358
50-Day Moving Average 22.4914
20-Day Moving Average 22.5385
10-Day Moving Average 22.499
Average True Range 0.9414
ADX 17.12
+DI 18.2
-DI 24.79
Chandelier Exit (Long, 3 ATRs ) 20.8358
Chandelier Exit (Short, 3 ATRs ) 23.8142
Upper Bollinger Band 23.5505
Lower Bollinger Band 21.5265
Percent B (%b) 0.57
BandWidth 8.980189
MACD Line 0.0995
MACD Signal Line 0.0032
MACD Histogram 0.0963
Fundamentals Value
Market Cap 834.58 Million
Num Shares 36.8 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -5.41
Price-to-Sales 56.93
Price-to-Book 2.96
PEG Ratio 0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.24
Resistance 3 (R3) 24.39 24.03 23.98
Resistance 2 (R2) 24.03 23.63 23.95 23.89
Resistance 1 (R1) 23.35 23.38 23.17 23.20 23.81
Pivot Point 22.99 22.99 22.90 22.91 22.99
Support 1 (S1) 22.31 22.59 22.13 22.16 21.55
Support 2 (S2) 21.95 22.34 21.87 21.47
Support 3 (S3) 21.27 21.95 21.38
Support 4 (S4) 21.12